News ReleaseTuesday, August 27, 2024
NIH study finds lung function remained stable or improved in adults after transplant. So-called low-intensity blood...
Enrollment ongoing in SZN-043 Phase 1b trial in patients with Severe Alcoholic HepatitisPresented first-in-human data from SZN-043 Phase 1a trial at EASLPublished study that...
-- Initiated Phase 3 SYNCHRONY Outcomes Trial of Lead Candidate Efruxifermin (EFX) in Patients with Compensated Cirrhosis (F4) Due to MASH-- Presented Poster and...
– Initiation of Phase 1 CALiPSO-1 Trial of CNTY-101 in Systemic Lupus Erythematosus, marking strategic expansion into autoimmune disease; protocol amended to include additional...
Data from INVOKE-2 Phase 2 clinical trial of AL002 in individuals with early Alzheimer’s disease (AD) on track for Q4 2024Patient baseline characteristics data...
